IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·
← Ticker index
MCK
Ticker

MCK

Congressional Trades
97
by 13 members
Ticker disclosure brief

Congressional disclosure records for MCK

A ticker-first view of recent disclosures, reported ranges, filing lags, party aggregates, federal awards, lobbying records, and source-linked receipts.

Latest receipt
Rick Larsen
BUY · 2026-07-08
Largest range
$15K – $50K
Ro Khanna
Longest observed gap
175d
Jonathan Jackson
Highest 30d vs SPY
41.3%
Ro Khanna
Purchase rows
50
52%
Sale rows
45
46%
Disclosed midpoint
$972K
range estimate
Unique Traders
13
members
Disclosure timing method

Observed filing gaps are not notice-date findings

The reporting deadline is the earlier of 30 days after notice or 45 days after the transaction. Public disclosure rows provide transaction and filing dates, but do not establish when a member received notice. PoliWealth therefore marks only transaction-to-filing gaps over 45 days as an apparent delay for review; 31–45 day gaps are not labeled late from transaction date alone.

Party Breakdown

Democrats86 · 89%
Republicans11 · 11%

Federal awards

all →
  • 2026-07-11$150K
    Department of Justice
    FY26 B1 MCKESSON CONTRACT MEDS JUL 26
  • 2026-07-09$275K
    Department of Justice
    FY26 B1 MCKESSON B12648613F MEDS AUG 26
  • 2026-07-09$65K
    Department of Justice
    FY26 B1 MCKESSON NON-CONT/CONT. JULY 2026
  • 2026-07-09$35K
    Department of Justice
    ESTIMATE FOR MEDICATIONS NEEDED FOR FOURTH QUARTER 2026.
  • 2026-07-09$31K
    Department of Justice
    FY26 B1 MCKESSON MEDICATION MAT QTR 4 MAT MEDICATION
  • 2026-07-09$14K
    Department of Justice
    MCKESSON DRUGS MEDICATIONS CONTRACT # 36W79720D0001 CURRENT PERFORMANCE PERIOD 8-10-24 TO 8-9-26 ALL TERMS AND CONDITIONS REMAIN THE SAME UNDER PARENT CONTRACT SAM VERIFIED
  • 2026-07-09$9K
    Department of Justice
    FY26 B1 FSA MCKESSON MAT MEDICATION JUL 26
  • 2026-07-09$6K
    Department of Justice
    RP# 26-81 MAT. MEDICATION BUPREN+NALOX /SUBOXONE SUBLING
  • 2026-07-09$795
    Department of Justice
    FY26 B1 MCKESSON MEDICATION JUL 26
  • 2026-07-09$465
    Department of Justice
    MCKESSON MAT CONTROL MEDICATIONS CONTRACT # 36W79720D0001 CURRENT PERFORMANCE PERIOD 8-10-24 TO 8-9-26 ALL TERMS AND CONDITIONS REMAIN THE SAME UNDER PARENT CONTRACT SAM VERIFIED

Lobbying filings

all →
  • 2026-04-20$860K
    MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS
    H.R. 3521, Clinical Trial Modernization Act; H.R. 1, One Big Beautiful Bill (Definition clarity around distributors);S. 3822, Break Up Big Medicine Act; Drug Shortages; Safe Step Act (not reintroduced in 119th) (Support establishing an exception to medication step-therapy protocol in specified cases). H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; H.R. 4299, Protecting Patient Access to Cancer and Complex
  • 2026-04-20$60K
    MCKESSON CORPATION AND ITS AFFILIATE US ONCOLOGY (FORMERLY US ONCOLOGY)
    Medicare, oncology, radiation and imaging reimbursement issues; medicare physician payments; Oncology payment disparities in Medicare.; Health information technology; application of the sequester to cancer drug reimbursement; prompt pay discount; safety and security of the prescription drug supply chain; HR4299, Protecting Patient Access to Cancer and Complex Therapies Act. H.R.2484, Seniors Access to Critical Medications Act of 2025
  • 2026-04-20$50K
    MCKESSON CORPORATION
    General Medicare/Medicaid Issues. Transparency Requirements. Emergency Preparedness.
  • 2026-04-20$50K
    MCKESSON CORPORATION
    Issues around interoperability, data privacy and sharing in healthcare, drug shortages and healthcare transparency, 2026 rule and drug reimbursement changes.
  • 2026-04-20$40K
    MCKESSON SPECIALTY HEALTH
    Radiation Oncology payment proposals in the CY 2026 Physician Fee Schedule proposed rule.
  • 2026-04-20$30K
    MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER
    H.R. 3521, Clinical Trial Modernization Act; H.R. 1, One Big Beautiful Bill (Definition clarity around distributors); Drug Shortages; Safe Step Act (not reintroduced in 119th) (Support establishing an exception to medication step-therapy protocol in specified cases). H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Pr
  • 2026-04-15$60K
    MCKESSON CORPORATION
    Issues related to the pharmaceutical supply chain and drug shortages. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.
  • 2026-02-13$0
    MCKESSON CORPORATION
    Issues around interoperability, data privacy and sharing in healthcare, drug shortages and healthcare transparency, 2026 rule and drug reimbursement changes.
  • 2026-01-20$60K
    MCKESSON CORPATION AND ITS AFFILIATE US ONCOLOGY (FORMERLY US ONCOLOGY)
    Medicare, oncology, radiation and imaging reimbursement issues; medicare physician payments; Oncology payment disparities in Medicare.; Health information technology; application of the sequester to cancer drug reimbursement; prompt pay discount; safety and security of the prescription drug supply chain. H.R.2484, Seniors Access to Critical Medications Act of 2025
  • 2026-01-20$50K
    MCKESSON CORPORATION
    General Medicare/Medicaid Issues. Transparency Requirements. Emergency Preparedness.
Loading trade analytics…

All Disclosed Trades

Page 2 · 25 of 97 shown
DateMemberActionAmountObserved GapReceipt
2025-10-10DJared MoskowitzBUY$1K – $15K43dreceipt →
2025-10-10DJared MoskowitzBUY$1K – $15K43dreceipt →
2025-10-08DJonathan JacksonSELL$1K – $15K34dreceipt →
2025-10-08DJonathan JacksonSELL$1K – $15K33dreceipt →
2025-10-08DJonathan JacksonSELL$1K – $15K33dreceipt →
2025-10-08DJonathan JacksonSELL$1K – $15K27dreceipt →
2025-10-10DJared MoskowitzBUY$1K – $15K21dreceipt →
2025-10-10DJared MoskowitzBUY$1K – $15K21dreceipt →
2025-09-23DValerie HoyleSELL$1K – $15K17dreceipt →
2025-09-10DValerie HoyleBUY$1K – $15K30dreceipt →
2025-09-23DValerie HoyleSELL$1K – $15K17dreceipt →
2025-09-10DValerie HoyleBUY$1K – $15K30dreceipt →
2025-09-29DRo KhannaSELL$1K – $15K4dreceipt →
2025-09-29DRo KhannaSELL$1K – $15K4dreceipt →
2025-08-05DGilbert CisnerosSELL$1K – $15K41dreceipt →
2025-08-05DGilbert CisnerosSELL$1K – $15K38dreceipt →
2025-08-05DGilbert CisnerosSELL$1K – $15K38dreceipt →
2025-04-23DJonathan JacksonBUY$1K – $15K125dApparent delayreceipt →
2025-04-23DJonathan JacksonBUY$1K – $15K124dApparent delayreceipt →
2025-03-24DJonathan JacksonBUY$1K – $15K154dApparent delayreceipt →
2025-03-03DJonathan JacksonBUY$1K – $15K175dApparent delayreceipt →
2025-03-24DJonathan JacksonBUY$1K – $15K154dApparent delayreceipt →
2025-07-11DRitchie TorresSELL$1K – $15K41dreceipt →
2025-07-11DRitchie TorresSELL$1K – $15K40dreceipt →
2025-07-11DRitchie TorresSELL$1K – $15K40dreceipt →

“Observed gap” is the calendar distance from transaction date to filing date; only gaps over 45 days receive an apparent-delay marker.